RTÉ News
UK · 10 hrs ago
HSE recommends not covering Friedreich's Ataxia drug cost
The HSE Drugs Group has decided to recommend that the drug Skyclarys, for Friedreich's Ataxia, should not be covered by the HSE.
Do you trust RTÉ News?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!